| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Quant Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.03 |
| Equity |
89.00 |
| Treasury Bill |
5.93 |
| Trep |
5.10 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
44.83% |
| Top 10 Holdings |
78.32% |
| Top 25 Holdings |
102.40% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
49.36 |
| Food Beverage & Tobacco |
9.27 |
| Healthcare |
8.9 |
| Miscellaneous |
8.15 |
| Telecom |
7.15 |
| SOV |
5.93 |
| Cash |
5.07 |
| Retail |
3.72 |
| Derivatives |
2.45 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.93 |
| PE Ratio |
46.90 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| EQ -ZYDUS WELLNESS LTD. |
9.27 |
| Anthem Biosciences Limited |
9.17 |
| (5) Total outstanding exposure in derivative instruments as on April 30, 2026 is Rs. Nil. |
8.90 |
| SMS Pharmaceuticals Limited |
8.87 |
| Sequent Scientific Limited |
8.62 |
| TREPS 04-May-2026 DEPO 10 |
7.50 |
| Alivus Life Sciences |
7.27 |
| HFCL Limited |
7.15 |
| Pfizer Limited |
6.42 |
| Aurobindo Pharma Limited |
5.15 |
| ICICI PRUDENTIAL LIFE INSURA L |
4.35 |
| HDFC Life Insurance Co Ltd |
3.80 |
| MedPlus Health Services Limited |
3.72 |
| Glaxosmithkline Pharma Ltd |
2.16 |
| 91 Days Treasury Bill 22-May-2026 |
1.70 |
| Gland Pharma Limited |
1.40 |
| ICICI Bank Limited 26/05/2026 |
1.34 |
| HDFC Life Insurance Co Ltd 26/05/2026 |
1.11 |
| 91 Days Treasury Bill 04-Jun-2026 |
0.85 |
| 91 Days Treasury Bill 14-May-2026 |
0.85 |
| 91 Days Treasury Bill 07-May-2026 |
0.85 |
| 91 Days Treasury Bill 23-Jul-2026 |
0.84 |
| 91 Days Treasury Bill 16-Jul-2026 |
0.84 |
| Strides Pharma Science Limited |
0.30 |
| Net Current Assets |
-0.03 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
